Publications by authors named "Johan Askling"

Claim this Profile
L
Letter to the Editor Regarding "Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases".
Claudia A Salinas, Anthony Louder, Jennifer Polinski, Tancy C Zhang, Hannah Bower, Johan Askling

Rheumatol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrix metalloproteinase 13 (MMP-13) processing of type II collagen is altered by antibodies and citrullination found in the early stages of rheumatoid arthritis.
Anna M Knapinska, Dorota Tokmina-Roszyk, Sabrina Haag, Jordan K Lauer-Fields, Chandani Singh, Johan Askling

Matrix Biol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal rheumatoid arthritis and the risk of offspring autism spectrum disorder: two national birth cohorts and a meta-analysis.
Evora Hailin Zhu, Benjamin Hk Yip, Caroline Fyfe, Eugene Merzon, Arad Kodesh, Johan Askling

Mol Autism· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple DMARD discontinuations in rheumatoid arthritis: how often and in what patients? Results from a national clinical RA register.
Emma Wettersand, Daniela di Giuseppe, Johan Askling, Katerina Chatzidionysiou

RMD Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the HLA Class II Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid Arthritis.
Linda Mathsson Alm, Helga Westerlind, Isabel Gehring, Monika Hansson, Nasim Ghasemzadeh, Johan Askling

Arthritis Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries.
Romain Aymon, Denis Mongin, Romain Guemara, Zubeyir Salis, Johan Askling

Arthritis Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of incident rheumatoid arthritis on earnings: a nationwide sibling comparison study.
Heather Miller, Martin Neovius, Johan Askling, Gustaf Bruze

Rheumatology (Oxford)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, stage and outcome of malignant melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?
Benedicte Delcoigne, Josefin Lysell, Johan Askling

Br J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common genetic variants do not impact clinical prediction of methotrexate treatment outcomes in early rheumatoid arthritis.
Anton Öberg Sysojev, Bénédicte Delcoigne, Thomas Frisell, Lars Alfredsson, Lars Klareskog, Johan Askling

J Intern Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult-onset inflammatory bowel disease and the risk of venous thromboembolism - a Swedish nationwide cohort study 2007-2021.
Gabriella Bröms, Anders Forss, Julia Eriksson, Johan Askling, Carl Eriksson

Scand J Gastroenterol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer incidence in patients with ulcerative colitis naïve to or treated with thiopurine and targeted therapies-a cohort study 2007 to 2022 with comparison to the general population.
Åsa H Everhov, Johan Askling, Jonas Söderling, Jonas Halfvarson, Julia Eriksson

J Crohns Colitis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritis.
Viktor Molander, Hannah Bower, Thomas Frisell, Johan Askling

Ann Rheum Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update.
Peter Nash, Andreas Kerschbaumer, Victoria Konzett, Daniel Aletaha, Thomas Dörner, Johan Askling

Ann Rheum Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-steroidal anti-inflammatory drugs and risk of kidney cancer: A Swedish nationwide cohort study in the general and high-use populations.
Hjalmar Wadström, Johan Askling, Rolf Gedeborg, Nils Feltelius, Karin Hellgren

J Intern Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[SRQ - a solution for quality control, clinical decision support and research in rheumatology].
Liselotte Tidblad, Johan Askling, Ewa Berglin, Lena Karlberg, Tor Olofsson

Lakartidningen· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag, Juan Molina-Collada, Ramatoulaye Ndoye, Daniel Aletaha, Johan Askling

Ann Rheum Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesity.
Liselotte Tidblad, Anton Öberg Sysojev, Bénédicte Delcoigne, Lars Klareskog, Lars Alfredsson, Johan Askling

RMD Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study.
Anna Eberhard, Daniela Di Giuseppe, Johan Askling, Stefan Bergman, Hannah Bower

Arthritis Rheumatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Juvenile Idiopathic Arthritis, Earnings, and Work Loss: A Nationwide Matched Cohort Study.
Heather Miller, Martin Neovius, Erik Sundberg, Johan Askling, Gustaf Bruze

Arthritis Care Res (Hoboken)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden.
Sofia Exarchou, Daniela Di Giuseppe, Eva Klingberg, Valgerdur Sigurdardottir, Sara Wedrén, Johan Askling

J Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to antibiotics and risk of latent autoimmune diabetes in adults and type 2 diabetes: results from a Swedish case-control study (ESTRID) and the Norwegian HUNT study.
Jessica Edstorp, Marios Rossides, Emma Ahlqvist, Lars Alfredsson, Johan Askling

Diabetologia· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the Link Between HLA-DRB1 Alleles and Autoantibodies in Rheumatoid Arthritis: Association of non-Shared Epitope Alleles *09 and *15 With High Levels of Anti-Citrullinated Peptide/Protein Antibodies.
Denis Lagutkin, Luis Panaifo, Ahmad-Fauzi Nurul-Aain, Lena Israelsson, Monika Hansson, Johan Askling

ACR Open Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors: a nationwide direct drug-to-drug comparison.
Gustaf Magnus Bruze, Thomas Frisell, Carl Turesson, Helena Forsblad-d'Elia, Jonas Soderling, Johan Askling

RMD Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Legal obstacles jeopardise research in personalised medicine - experiences from a Nordic collaboration within rheumatology.
Bente Glintborg, Mats Hansson, Hilde Berner Hammer, Lars Klareskog, Saedis Saevarsdottir, Johan Askling

Scand J Public Health· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag, Kim Lauper, Juan Molina-Collada, Daniel Aletaha, Johan Askling

Ann Rheum Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis